Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized Study - Concepedia

Concepedia

Publication | Open Access

Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized Study

DOI Full Paper Access

69

Citations

11

References

2022

Year

Aldo Marrone, Riccardo Nevola, Ausilia Sellitto, Domenico Cozzolino, Ciro Romano, Giovanna Cuomo, Concetta Aprea, Michelangelo X Palou Schwartzbaum, Carmen Ricozzi, Simona Imbriani,

Clinical Infectious Diseases

Abstract

Remdesivir/dexamethasone treatment is associated with significant reduction in mortality, length of hospitalization, and faster SARS-CoV-2 clearance, compared to dexamethasone alone.

References

	Year	Citations

Page 1